Here’s what you need to know:
1. Ms. Dixon is an irritable bowel syndrome with diarrhea, or IBS-D, patient.
2. Ms. Dixon will act as a spokesperson for Allergan, in which she will “share her story with fellow IBS-D sufferers and healthcare providers,” according to a news release. Her ultimate goal is to increase communication about IBS.
3. A major barrier to IBS diagnosis is lack of communication between patients and physicians, according to a recent survey commissioned by the American Gastroenterological Association, titled “IBS in America .”
4. Allergan will develop a website dedicated to “Amy’s Story,” which will include a physician discussion guide.
More articles on gastroenterology and endoscopy:
50% of patients treated with Kanuma experience reduced liver fibrosis: 3 study insights
Takeda Pharmaceutical, New York Academy of Sciences establish $200k research prize: 3 notes
AGA, NACCME develop 3 regional educational programs about IBD: 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
